H.R. 3146House117th Congress (2021-2023)Passed House

SAVE Act of 2021

Introduced May 12, 2021

AI-Generated Summary

Updated February 8, 2026 at 2:55 AM UTC

The Securing America’s Vaccines for Emergencies (SAVE) Act amends the Defense Production Act to give the government clearer authority to protect the supply of medical products needed for national defense, such as vaccines, drugs, and devices. It requires the President, in consultation with key cabinet secretaries, to develop and report a strategy for securing medical supply chains and allows the President to fund U.S. entities that improve those supply chains.

Key Provisions

  • Adds a new policy paragraph to the Defense Production Act stating its authorities can be used to ensure availability of essential medical materials for national defense.
  • Expands existing DPA sections to explicitly include medical materials—drugs, devices, and biological products—in definitions of “materials” and “essential materials.”
  • Mandates the President, with the Secretaries of Health and Human Services, Commerce, Homeland Security, and Defense, to submit a detailed supply‑chain strategy within 180 days, covering a plan, vulnerability analysis, diversification measures, impact assessments, timelines to avoid foreign control, and cooperation with allies.
  • Requires annual unclassified progress reports on the strategy through September 30, 2025, with possible classified annexes.
  • Allows the President to make payments to eligible U.S. entities that produce critical components, technology, or materials to improve supply‑chain security, after certifying the payment is critical to national defense.
  • Directs the President to issue regulations within 90 days defining “supply chain” and “supply chain activities” for use in the new payment authority.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

8 earlier actions
SenateIntro Referral Latest Action

Received in the Senate and Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.

May 19, 2021

View full timeline
HouseIntro Referral

Introduced in House

May 12, 2021

HouseIntro Referral

Referred to the House Committee on Financial Services.

May 12, 2021

HouseFloor

Mr. Cleaver moved to suspend the rules and pass the bill.

May 18, 2021 • 1:00 PM

HouseFloor

Considered under suspension of the rules. (consideration: CR H2454-2456)

May 18, 2021 • 1:00 PM

HouseFloor

DEBATE - The House proceeded with forty minutes of debate on H.R. 3146.

May 18, 2021 • 1:00 PM

HouseFloor

Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H2454-2455)

May 18, 2021 • 1:13 PM

HouseFloor

On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2454-2455)

May 18, 2021 • 1:13 PM

HouseFloor

Motion to reconsider laid on the table Agreed to without objection.

May 18, 2021 • 1:13 PM

SenateIntro Referral

Received in the Senate and Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.

May 19, 2021

Floor Debate

24 members

What members said about H.R. 3146 on the floor

7 Republicans17 Democrats
Gerald E. Connolly
Rep. Gerald E. ConnollyD-VA-11 · Sep 22, 2021

Madam Speaker, in February of this year, more than two years after the cold-blooded murder of Washington Post journalist, and my constituent, Jamal Khashoggi, the Director of National Intelligence…

Jamaal Bowman
Rep. Jamaal BowmanD-NY-16 · Sep 22, 2021

Madam Speaker, I have an amendment at the desk. Madam Speaker, I yield myself such time as I may consume. Madam Speaker, I rise today to urge support for my amendment that will take an important step…

Mike Rogers
Rep. Mike RogersR-AL-3 · Sep 22, 2021

Madam Speaker, I yield myself such time as I may consume. Madam Speaker, this is an en bloc that was put together in close consultation with the minority. I urge all Members to support it, and I…

Joe Wilson
Rep. Joe WilsonR-SC-2 · Sep 22, 2021

Madam Speaker, I rise in opposition. Madam Speaker, as I begin, I was grateful to support the prior amendment that we just had by President Gerry Connolly and also Congressman Steve Chabot, but I…

Liz Cheney
Rep. Liz CheneyR-WY · Sep 22, 2021

Madam Speaker, I rise in support of my amendments included in En Bloc No. 1. My first amendment, No. 100, would require DoD to develop more distributed military and Intelligence Community satellite…

Show 8 more
J. French Hill
Rep. J. French HillR-AR-2 · May 18, 2021

Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise today in support of H.R. 3146, the Securing America's Vaccines for Emergencies Act, the SAVE Act. I want to thank my friend…

Alexandria Ocasio-Cortez
Rep. Alexandria Ocasio-CortezD-NY-14 · Sep 22, 2021

Mr. Speaker, today I rise to offer amendment 40, as the designee of Congressman Mark Pocan, to reduce the Pentagon budget by 10 percent. Mr. Speaker, I rise today to offer amendment 40, to reduce the…

James R. Langevin
Rep. James R. LangevinD-RI-2 · Sep 22, 2021

Mr. Speaker, I have an amendment at the desk. Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, the United States attracts and develops some of the brightest minds in the world.…

Pat Fallon
Rep. Pat FallonR-TX-4 · Sep 22, 2021

Madam Speaker, I rise in opposition to the amendment. Madam Speaker, I rise in opposition to amendment 35, and I yield myself such time as I may consume. The amendment would establish an online…

Henry C. "Hank" Johnson, Jr.
Rep. Henry C. "Hank" Johnson, Jr.D-GA-4 · Sep 22, 2021

Mr. Speaker, I have an amendment at the desk. Mr. Speaker, I rise in support of my bipartisan amendment to end the Defense Department's militarization of police departments across the Nation. I think…

Carolyn B. Maloney
Rep. Carolyn B. MaloneyD-NY-12 · Sep 22, 2021

Madam Speaker, I have an amendment at the desk. Madam Speaker, I rise today in support of this amendment, which contains my bill to increase transparency and accountability of senior leaders in the…

Robert C. "Bobby" Scott
Rep. Robert C. "Bobby" ScottD-VA-3 · Sep 22, 2021

Madam Speaker, I rise today in opposition to Amendment No. 3, which directs the Office of Management and Budget (OMB) to reclassify public safety telecommunications officers, also called 911…

John Garamendi
Rep. John GaramendiD-CA-3 · Sep 22, 2021

Mr. Speaker, I have an amendment at the desk. Mr. Speaker, the United States, Russia, and China are aggressively engaged in a new nuclear arms race. The rapid development by all three nations of new…

Show 11 more
Kweisi Mfume
Rep. Kweisi MfumeD-MD-7 · Sep 22, 2021

Madam Speaker, I have an amendment at the desk. Madam Speaker, I rise in support of the Mfume-Neguse amendment which will codify Congress' support for small businesses across the country,…

Thomas P. Tiffany
Rep. Thomas P. TiffanyR-WI-7 · Sep 22, 2021

Mr. Speaker, I rise in opposition to the amendment. Mr. Speaker, I yield myself such time as I may consume. The ramifications of this amendment could be dangerous and far- reaching. Quite frankly, we…

Kurt Schrader
Rep. Kurt SchraderD-OR-5 · Sep 22, 2021

Mr. Speaker, I have an amendment at the desk. Mr. Speaker, I rise today to offer an amendment to this year's National Defense Authorization Act to help rein in a practice that has existed from the…

Sara Jacobs
Rep. Sara JacobsD-CA-53 · Sep 22, 2021

Mr. Speaker, I rise to offer amendment No. 41 as the designee of Ms. Lee of California. Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, this amendment offered by my friend and…

André Carson
Rep. André CarsonD-IN-7 · Sep 22, 2021

Madam Speaker, I rise today in support of the National Defense Authorization Act (NDDA) and my bipartisan amendment which authorizes an increase of five million dollars for a pancreatic cancer early…

Daniel Meuser
Rep. Daniel MeuserR-PA-9 · Sep 22, 2021

Madam Speaker, I rise in opposition to the amendment. Madam Speaker, though I agree with Mr. Mfume that we need to find ways to incentivize and encourage agencies to contract with small businesses,…

Sheila Jackson Lee
Rep. Sheila Jackson LeeD-TX-18 · Sep 22, 2021

Mr. Speaker, I thank the chairman, and I thank the ranking member for his support, longtime friends. Let me quickly indicate that as I have embraced the NDAA over the years, it has always been my…

Gregory W. Meeks
Rep. Gregory W. MeeksD-NY-5 · Sep 22, 2021

Madam Speaker, I have an amendment at the desk. Madam Speaker, I rise to speak on Meeks amendment No. 30. The facts are plain. Saudi Arabia and its partners have perpetuated a catastrophic and…

Ro Khanna
Rep. Ro KhannaD-CA-17 · Sep 22, 2021

Madam Speaker, I have an amendment at the desk. Madam Speaker, I rise to offer my amendment with Chairman Smith, with Chairman Schiff, and Representative Jayapal, to finally end the humanitarian…

Adam Smith
Rep. Adam SmithD-WA-9 · Sep 22, 2021

Madam Speaker, pursuant to House Resolution 667, I offer amendments en bloc. Madam Speaker, I yield 1\1/2\ minutes to the gentleman from Oregon (Mr. Blumenauer). Madam Speaker, I yield 1 minute to…

Emanuel Cleaver
Rep. Emanuel CleaverD-MO-5 · May 18, 2021

Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 3146) to amend the Defense Production Act of 1950 to ensure the supply of certain medical materials essential to national defense, and…

Bill Text

3 versions available

Reading Mode
Latest
Referred in SenateIssued May 19, 2021

IIB

117th CONGRESS

1st Session

H. R. 3146

IN THE SENATE OF THE UNITED STATES

May 19, 2021

Received; read twice and referred to the Committee on Banking, Housing, and Urban Affairs

AN ACT

To amend the Defense Production Act of 1950 to ensure the supply of certain medical materials essential to national defense, and for other purposes.

1.

Short title

This Act may be cited as the Securing America’s Vaccines for Emergencies Act of 2021 or the SAVE Act of 2021.

2.

Securing essential medical materials

(a)

Statement of policy

Section 2(b) of the Defense Production Act of 1950 (50 U.S.C. 4502) is amended—

(1)

by redesignating paragraphs (3) through (8) as paragraphs (4) through (9), respectively; and

(2)

by inserting after paragraph (2) the following:

(3)

authorities under this Act should be used when appropriate to ensure the availability of medical materials essential to national defense, including through measures designed to secure the drug supply chain, and taking into consideration the importance of United States competitiveness, scientific leadership and cooperation, and innovative capacity;

.

(b)

Strengthening domestic capability

Section 107 of the Defense Production Act of 1950 (50 U.S.C. 4517) is amended—

(1)

in subsection (a), by inserting (including medical materials) after materials; and

(2)

in subsection (b)(1), by inserting (including medical materials such as drugs, devices, and biological products to diagnose, cure, mitigate, treat, or prevent disease that are essential to national defense) after essential materials.

(c)

Strategy on securing supply chains for medical materials

Title I of the Defense Production Act of 1950 (50 U.S.C. 4511 et seq.) is amended by adding at the end the following:

109.

Strategy on securing supply chains for medical materials

(a)

In general

Not later than 180 days after the date of the enactment of this section, the President, in consultation with the Secretary of Health and Human Services, the Secretary of Commerce, the Secretary of Homeland Security, and the Secretary of Defense, shall transmit a strategy to the appropriate Members of Congress that includes the following:

(1)

A detailed plan to use the authorities under this title and title III, or any other provision of law, to ensure the supply of medical materials (including drugs, devices, and biological products (as that term is defined in section 351 of the Public Health Service Act (42 U.S.C. 262)) to diagnose, cure, mitigate, treat, or prevent disease) essential to national defense, to the extent necessary for the purposes of this Act.

(2)

An analysis of vulnerabilities to existing supply chains for such medical materials, and recommendations to address the vulnerabilities.

(3)

Measures to be undertaken by the President to diversify such supply chains, as appropriate and as required for national defense.

(4)

A discussion of—

(A)

any significant effects resulting from the plan and measures described in this subsection on the production, cost, or distribution of biological products (as that term is defined in section 351 of the Public Health Service Act (42 U.S.C. 262)) or any other devices or drugs (as defined under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.));

(B)

a timeline to ensure that essential components of the supply chain for medical materials are not under the exclusive control of a foreign government in a manner that the President determines could threaten the national defense of the United States; and

(C)

efforts to mitigate any risks resulting from the plan and measures described in this subsection to United States competitiveness, scientific leadership, and innovative capacity, including efforts to cooperate and proactively engage with United States allies.

(b)

Progress Report

Following submission of the strategy under subsection (a), the President shall submit to the appropriate Members of Congress an annual progress report until September 30, 2025, evaluating the implementation of the strategy, and may include updates to the strategy as appropriate. The strategy and progress reports shall be submitted in unclassified form but may contain a classified annex.

(c)

Appropriate Members of Congress

The term appropriate Members of Congress means the Speaker, majority leader, and minority leader of the House of Representatives, the majority leader and minority leader of the Senate, the Chairman and Ranking Member of the Committee on Financial Services of the House of Representatives, and the Chairman and Ranking Member of the Committee on Banking, Housing, and Urban Affairs of the Senate.

.

3.

Investment in supply chain security

(a)

In general

Section 303 of the Defense Production Act of 1950 (50 U.S.C. 4533) is amended by adding at the end the following:

(h)

Investment in supply chain security

(1)

In general

In addition to other authorities in this title, the President may make available to an eligible entity described in paragraph (2) payments to increase the security of supply chains and supply chain activities, if the President certifies to Congress not less than 30 days before making such a payment that the payment is critical to meet national defense requirements of the United States.

(2)

Eligible entity

An eligible entity described in this paragraph is an entity that—

(A)

is organized under the laws of the United States or any jurisdiction within the United States; and

(B)

produces—

(i)

one or more critical components;

(ii)

critical technology; or

(iii)

one or more products or raw materials for the security of supply chains or supply chain activities.

(3)

Definitions

In this subsection, the terms supply chain and supply chain activities have the meanings given those terms by the President by regulation.

.

(b)

Regulations

(1)

In general

Not later than 90 days after the date of the enactment of this Act, the President shall prescribe regulations setting forth definitions for the terms supply chain and supply chain activities for the purposes of section 303(h) of the Defense Production Act of 1950 (50 U.S.C. 4533(h)), as added by subsection (a).

(2)

Scope of definitions

The definitions required by paragraph (1)—

(A)

shall encompass—

(i)

the organization, people, activities, information, and resources involved in the delivery and operation of a product or service used by the Government; or

(ii)

critical infrastructure as defined in Presidential Policy Directive 21 (February 12, 2013; relating to critical infrastructure security and resilience); and


(B)

may include variations as determined necessary and appropriate by the President for purposes of national defense.

Passed the House of Representatives May 18, 2021.

Cheryl L. Johnson,

Clerk